Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
American Heart Journal
|
June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Annals of Cardiothoracic Surgery
|
February 12, 2014
Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III
Richard Whitlock, Jeff Healey, Jessica Vincent, et al.
British Journal of Anaesthesia
|
May 18, 2020
Restricted versus liberal intraoperative benzodiazepine use in cardiac anaesthesia for reducing delirium (B-Free Pilot): a pilot, multicentre, randomised, cluster crossover trial
Jessica Spence, Emilie Belley-Côté, Eric Jacobsohn, et al.
Annals of Emergency Medicine
|
December 4, 2018
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED)
Ratika Parkash, Kirk Magee, Mark McMullen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
January 24, 2024
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC
Bernhard M Siepen, Alexandros Polymeris, Ashkan Shoamanesh, et al.
Journal of the American College of Cardiology
|
January 19, 2019
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study
Andre Lamy, John Eikelboom, Tej Sheth, et al.
The Canadian Journal of Cardiology
|
September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Laurent Macle, John Cairns, Kori Leblanc, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Andre Lamy, John Eikelboom, Wesley Tong, et al.
European Journal of Heart Failure
|
November 25, 2024
Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial
Philipp Krisai, Emilie P Belley-Cote, William F McIntyre, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
August 24, 2022
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial
Andre Lamy, John Eikelboom, Wesley Tong, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
American Heart Journal
|
June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Annals of Cardiothoracic Surgery
|
February 12, 2014
Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III
Richard Whitlock, Jeff Healey, Jessica Vincent, et al.
British Journal of Anaesthesia
|
May 18, 2020
Restricted versus liberal intraoperative benzodiazepine use in cardiac anaesthesia for reducing delirium (B-Free Pilot): a pilot, multicentre, randomised, cluster crossover trial
Jessica Spence, Emilie Belley-Côté, Eric Jacobsohn, et al.
Annals of Emergency Medicine
|
December 4, 2018
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED)
Ratika Parkash, Kirk Magee, Mark McMullen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
January 24, 2024
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC
Bernhard M Siepen, Alexandros Polymeris, Ashkan Shoamanesh, et al.
Journal of the American College of Cardiology
|
January 19, 2019
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study
Andre Lamy, John Eikelboom, Tej Sheth, et al.
The Canadian Journal of Cardiology
|
September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Laurent Macle, John Cairns, Kori Leblanc, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Andre Lamy, John Eikelboom, Wesley Tong, et al.
European Journal of Heart Failure
|
November 25, 2024
Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial
Philipp Krisai, Emilie P Belley-Cote, William F McIntyre, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
August 24, 2022
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial
Andre Lamy, John Eikelboom, Wesley Tong, et al.
Page
of 7